Exploration of Neuroprotective Therapy (ENT, eISSN 2769-6510) is extremely excited to announce its successful inclusion in the Emerging Sources Citation Index (ESCI) of the Web of Science Core Collection, following a rigorous evaluation process conducted by Clarivate. The journal is expected to receive its first Journal Impact Factor in June 2027. 

This achievement marks a significant milestone in the journal’s development and reflects its growing recognition within the international scientific community. Inclusion in ESCI confirms that the journal meets recognized international standards in editorial quality, publishing best practices, publication ethics, and academic integrity. This recognition also reflects the collective dedication of our Editor-in-Chief, editorial board members, reviewers, authors, and colleagues/readers who have contributed to the journal’s growth since its inception. We extend our heartfelt gratitude to all who have supported and contributed to this achievement.

Since its launch in 2021, ENT has been dedicated to advancing research in neurodegenerative diseases, neuroprotection, and neurorestoration. Through the collective efforts of its editorial board, authors, reviewers, and readers, the journal has continued to strengthen its scientific impact and international presence. The journal is currently indexed in ESCI, Scopus, DOAJ, Google Scholar, CAS, and other databases.

Looking ahead, ENT remains committed to upholding rigorous peer review standards, publishing impactful and innovative research, and serving as an international platform for scholarly exchange in this field. As ENT enters this new stage, we warmly invite researchers worldwide to submit their latest discoveries and join us in advancing the understanding and treatment of neurological disorders through high-quality scientific research. Submissions received before July 31, 2026 will continue to enjoy the free publication with ESCI and Scopus indexing.